Статті в журналах з теми "Mutant p53 gain of function"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Mutant p53 gain of function".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Stein, Yan, Varda Rotter, and Ronit Aloni-Grinstein. "Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis." International Journal of Molecular Sciences 20, no. 24 (December 8, 2019): 6197. http://dx.doi.org/10.3390/ijms20246197.
Повний текст джерелаHall, Callum, and Patricia A. J. Muller. "The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer." International Journal of Molecular Sciences 20, no. 24 (December 7, 2019): 6188. http://dx.doi.org/10.3390/ijms20246188.
Повний текст джерелаChen, Sisi, Hao Yu, Michihiro Kobayashi, Rui Gao, H. Scott Boswell, and Yan Liu. "Gain-of-Function Mutant p53 Enhances Hematopoietic Stem Cell Self-Renewal." Blood 124, no. 21 (December 6, 2014): 260. http://dx.doi.org/10.1182/blood.v124.21.260.260.
Повний текст джерелаChiang, Yen-Ting, Yi-Chung Chien, Yu-Heng Lin, Hui-Hsuan Wu, Dung-Fang Lee, and Yung-Luen Yu. "The Function of the Mutant p53-R175H in Cancer." Cancers 13, no. 16 (August 13, 2021): 4088. http://dx.doi.org/10.3390/cancers13164088.
Повний текст джерелаOren, M., and V. Rotter. "Mutant p53 Gain-of-Function in Cancer." Cold Spring Harbor Perspectives in Biology 2, no. 2 (December 16, 2009): a001107. http://dx.doi.org/10.1101/cshperspect.a001107.
Повний текст джерелаAschauer, Lydia, and Patricia A. J. Muller. "Novel targets and interaction partners of mutant p53 Gain-Of-Function." Biochemical Society Transactions 44, no. 2 (April 11, 2016): 460–66. http://dx.doi.org/10.1042/bst20150261.
Повний текст джерелаZhang, Yanhong, Wensheng Yan, and Xinbin Chen. "Mutant p53 Disrupts MCF-10A Cell Polarity in Three-dimensional Culture via Epithelial-to-mesenchymal Transitions." Journal of Biological Chemistry 286, no. 18 (March 22, 2011): 16218–28. http://dx.doi.org/10.1074/jbc.m110.214585.
Повний текст джерелаZhang, Cen, Juan Liu, Dandan Xu, Tianliang Zhang, Wenwei Hu, and Zhaohui Feng. "Gain-of-function mutant p53 in cancer progression and therapy." Journal of Molecular Cell Biology 12, no. 9 (July 28, 2020): 674–87. http://dx.doi.org/10.1093/jmcb/mjaa040.
Повний текст джерелаCai, Bi-He, Zhi-Yu Bai, Ching-Feng Lien, Si-Jie Yu, Rui-Yu Lu, Ming-Han Wu, Wei-Chen Wu, Chia-Chi Chen, and Yi-Chiang Hsu. "NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner." Biomolecules 12, no. 3 (March 12, 2022): 438. http://dx.doi.org/10.3390/biom12030438.
Повний текст джерелаZhang, Ying, Feng Yuan, Cassandra Grello, Brian Reon, Myron Gibert, Collin Dube, Anindya Dutta, Eric Holland, and Roger Abounader. "CSIG-07. GAIN-OF-FUNCTION MUTANT P53 REGULATES LONG-NONCODING RNAS IN GLIOBLASTOMA." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii39—vii40. http://dx.doi.org/10.1093/neuonc/noac209.156.
Повний текст джерелаBargonetti, Jill, and Carol Prives. "Gain-of-function mutant p53: history and speculation." Journal of Molecular Cell Biology 11, no. 7 (July 2019): 605–9. http://dx.doi.org/10.1093/jmcb/mjz067.
Повний текст джерелаStindt, M., P. Muller, and K. H. Vousden. "151 Mutant P53 Gain of Function Via P63." European Journal of Cancer 48 (July 2012): S36—S37. http://dx.doi.org/10.1016/s0959-8049(12)70851-1.
Повний текст джерелаBarta, Julie A., Kristen Pauley, Andrew V. Kossenkov, and Steven B. McMahon. "The lung-enriched p53 mutants V157F and R158L/P regulate a gain of function transcriptome in lung cancer." Carcinogenesis 41, no. 1 (May 8, 2019): 67–77. http://dx.doi.org/10.1093/carcin/bgz087.
Повний текст джерелаZhao, Y., C. Zhang, X. Yue, X. Li, J. Liu, H. Yu, V. A. Belyi, Q. Yang, Z. Feng, and W. Hu. "Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53." Cell Death & Differentiation 22, no. 11 (April 10, 2015): 1824–36. http://dx.doi.org/10.1038/cdd.2015.33.
Повний текст джерелаZhao, Yuhan, Xuetian Yue, and Wenwei Hu. "Pontin, a novel interactor of mutant p53 that promotes mutant p53 gain of function." Molecular & Cellular Oncology 3, no. 2 (July 29, 2015): e1076587. http://dx.doi.org/10.1080/23723556.2015.1076587.
Повний текст джерелаAubrey, Brandon James, Andreas Strasser, Gemma Kelly, Lin Tai, and Marco Herold. "Evidence for Mutant p53 Gain-of-Function Effects in Normal Haemopoietic Cells and Myc-Driven Lymphoma." Blood 124, no. 21 (December 6, 2014): 3589. http://dx.doi.org/10.1182/blood.v124.21.3589.3589.
Повний текст джерелаRockwell, Nathan, Max Staller, Maria Cannella, Barak Cohen, and Joshua Rubin. "GENE-59. NOT ALL p53 MUTATIONS ARE CREATED EQUAL: A MURINE ASTROCYTE MODEL FOR HIGH-THROUGHPUT FUNCTIONAL ASSESSMENT OF p53 MISSENSE MUTATIONS." Neuro-Oncology 21, Supplement_6 (November 2019): vi110. http://dx.doi.org/10.1093/neuonc/noz175.461.
Повний текст джерелаLakoduk, Ashley M., Cheng-Fan Lee, and Ping-Hung Chen. "Gain-of-“endocytic’ function in mutant p53 cancer cells." International Journal of Biochemistry & Cell Biology 131 (February 2021): 105905. http://dx.doi.org/10.1016/j.biocel.2020.105905.
Повний текст джерелаPeart, Melissa J., and Carol Prives. "Mutant p53 gain of function: The NF-Y connection." Cancer Cell 10, no. 3 (September 2006): 173–74. http://dx.doi.org/10.1016/j.ccr.2006.08.014.
Повний текст джерелаStrano, Sabrina, Stefania Dell'Orso, Adriana Maria Mongiovi, Olimpia Monti, Eleonora Lapi, Silvia Di Agostino, Giulia Fontemaggi, and Giovanni Blandino. "Mutant p53 proteins: Between loss and gain of function." Head & Neck 29, no. 5 (2007): 488–96. http://dx.doi.org/10.1002/hed.20531.
Повний текст джерелаWang, Jieqiong. "Abstract 1035: VCP/p97 promotes pancreatic cancer growth by enhancing mutant p53 activity." Cancer Research 82, no. 12_Supplement (June 15, 2022): 1035. http://dx.doi.org/10.1158/1538-7445.am2022-1035.
Повний текст джерелаXiong, Shunbin, Dhruv Chachad, Yun Zhang, Jovanka Gencel-Augusto, Mario Sirito, Vinod Pant, Peirong Yang, Chang Sun, and Guillermina Lozano. "Abstract A042: Differences in gain-of-function and inhibitory effects amongst p53 mutants in vivo." Cancer Research 83, no. 2_Supplement_2 (January 15, 2023): A042. http://dx.doi.org/10.1158/1538-7445.metastasis22-a042.
Повний текст джерелаVikhanskaya, F., M. K. Lee, M. Mazzoletti, M. Broggini, and K. Sabapathy. "Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53." Nucleic Acids Research 35, no. 6 (March 1, 2007): 2093–104. http://dx.doi.org/10.1093/nar/gkm099.
Повний текст джерелаHann, Byron, and Allan Balmain. "Replication of an E1B 55-Kilodalton Protein-Deficient Adenovirus (ONYX-015) Is Restored by Gain-of-Function Rather than Loss-of-Function p53 Mutants." Journal of Virology 77, no. 21 (November 1, 2003): 11588–95. http://dx.doi.org/10.1128/jvi.77.21.11588-11595.2003.
Повний текст джерелаRockwell, Nathan C., Wei Yang, Nicole M. Warrington, Max V. Staller, Malachi Griffith, Obi L. Griffith, Christina A. Gurnett, Barak A. Cohen, Dustin Baldridge, and Joshua B. Rubin. "Sex- and Mutation-Specific p53 Gain-of-Function Activity in Gliomagenesis." Cancer Research Communications 1, no. 3 (December 2021): 148–63. http://dx.doi.org/10.1158/2767-9764.crc-21-0026.
Повний текст джерелаRoszkowska, Katarzyna A., Aleksandra Piecuch, Maria Sady, Zdzisław Gajewski, and Sylwia Flis. "Gain of Function (GOF) Mutant p53 in Cancer—Current Therapeutic Approaches." International Journal of Molecular Sciences 23, no. 21 (October 31, 2022): 13287. http://dx.doi.org/10.3390/ijms232113287.
Повний текст джерелаSchulz-Heddergott, Ramona, and Ute Moll. "Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target." Cancers 10, no. 6 (June 7, 2018): 188. http://dx.doi.org/10.3390/cancers10060188.
Повний текст джерелаFrazier, Mark W., Xiaoping He, JinLing Wang, Zhengming Gu, John L. Cleveland, and Gerard P. Zambetti. "Activation of c-myc Gene Expression by Tumor-Derived p53 Mutants Requires a Discrete C-Terminal Domain." Molecular and Cellular Biology 18, no. 7 (July 1, 1998): 3735–43. http://dx.doi.org/10.1128/mcb.18.7.3735.
Повний текст джерелаDonzelli, Sara, Francesca Biagioni, Francesca Fausti, Sabrina Strano, Giulia Fontemaggi, and Giovanni Blandino. "Oncogenomic Approaches in Exploring Gain of Function of Mutant p53." Current Genomics 9, no. 3 (May 1, 2008): 200–207. http://dx.doi.org/10.2174/138920208784340713.
Повний текст джерелаXiong, S., H. Tu, M. Kollareddy, V. Pant, Q. Li, Y. Zhang, J. G. Jackson, et al. "Pla2g16 phospholipase mediates gain-of-function activities of mutant p53." Proceedings of the National Academy of Sciences 111, no. 30 (July 14, 2014): 11145–50. http://dx.doi.org/10.1073/pnas.1404139111.
Повний текст джерелаYue, Xuetian, Yuhan Zhao, Yang Xu, Min Zheng, Zhaohui Feng, and Wenwei Hu. "Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy." Journal of Molecular Biology 429, no. 11 (June 2017): 1595–606. http://dx.doi.org/10.1016/j.jmb.2017.03.030.
Повний текст джерелаZhang, Y., S. V. Coillie, J.-Y. Fang, and J. Xu. "Gain of function of mutant p53: R282W on the peak?" Oncogenesis 5, no. 2 (February 2016): e196-e196. http://dx.doi.org/10.1038/oncsis.2016.8.
Повний текст джерелаYamamoto, Satomi, and Tomoo Iwakuma. "Regulators of Oncogenic Mutant TP53 Gain of Function." Cancers 11, no. 1 (December 20, 2018): 4. http://dx.doi.org/10.3390/cancers11010004.
Повний текст джерелаDeppert, Wolfgang, Thomas G�hler, Hisashi Koga, and Ella Kim. "Mutant p53: ?gain of function? through perturbation of nuclear structure and function?" Journal of Cellular Biochemistry 79, S35 (2000): 115–22. http://dx.doi.org/10.1002/1097-4644(2000)79:35+<115::aid-jcb1134>3.0.co;2-u.
Повний текст джерелаRockwell, Nathan, Nicole Warrington, and Joshua Rubin. "CBIO-22. p53 GAIN-OF-FUNCTION MUTATIONS DRIVE SEX SPECIFIC EFFECTS ON GLIOMA TUMORIGENESIS." Neuro-Oncology 22, Supplement_2 (November 2020): ii20. http://dx.doi.org/10.1093/neuonc/noaa215.082.
Повний текст джерелаCai, Bi-He, Yun-Chien Hsu, Fang-Yu Yeh, Yu-Rou Lin, Rui-Yu Lu, Si-Jie Yu, Jei-Fu Shaw, et al. "P63 and P73 Activation in Cancers with p53 Mutation." Biomedicines 10, no. 7 (June 23, 2022): 1490. http://dx.doi.org/10.3390/biomedicines10071490.
Повний текст джерелаCandelaria, Nicholes, Achuth Padmanabhan, Rainer Lanz, Kwong Wong, and JoAnne S. Richards. "P53 Gain-of-Function Mutants and Steroids in Ovarian Cancer Cell Metastasis." Journal of the Endocrine Society 5, Supplement_1 (May 1, 2021): A770—A771. http://dx.doi.org/10.1210/jendso/bvab048.1567.
Повний текст джерелаKalo, Eyal, Yosef Buganim, Keren E. Shapira, Hilla Besserglick, Naomi Goldfinger, Lilach Weisz, Perry Stambolsky, Yoav I. Henis та Varda Rotter. "Mutant p53 Attenuates the SMAD-Dependent Transforming Growth Factor β1 (TGF-β1) Signaling Pathway by Repressing the Expression of TGF-β Receptor Type II". Molecular and Cellular Biology 27, № 23 (17 вересня 2007): 8228–42. http://dx.doi.org/10.1128/mcb.00374-07.
Повний текст джерелаHe, Chao, Lun Li, Xuan Guan, Li Xiong, and Xiongying Miao. "Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical Chemotherapy." Chemotherapy 62, no. 1 (June 21, 2016): 43–53. http://dx.doi.org/10.1159/000446361.
Повний текст джерелаYang, Hao, Ke Zhang, Yusheng Guo, Xin Guo, Kailong Hou, Jing Hou, Ying Luo, Jing Liu та Shuting Jia. "Gain-of-Function p53N236S Mutation Drives the Bypassing of HRasV12-Induced Cellular Senescence via PGC–1α". International Journal of Molecular Sciences 24, № 4 (14 лютого 2023): 3790. http://dx.doi.org/10.3390/ijms24043790.
Повний текст джерелаAnnor, George Kwakye. "Abstract P5-09-02: Tetrameric and monomeric gain-of-function mutant p53 interacts with chromatin." Cancer Research 82, no. 4_Supplement (February 15, 2022): P5–09–02—P5–09–02. http://dx.doi.org/10.1158/1538-7445.sabcs21-p5-09-02.
Повний текст джерелаGomes, Ana Sara, Helena Ramos, Alberto Inga, Emília Sousa, and Lucília Saraiva. "Structural and Drug Targeting Insights on Mutant p53." Cancers 13, no. 13 (July 3, 2021): 3344. http://dx.doi.org/10.3390/cancers13133344.
Повний текст джерелаStein, Yan, Ronit Aloni-Grinstein, and Varda Rotter. "Mutant p53—a potential player in shaping the tumor–stroma crosstalk." Journal of Molecular Cell Biology 11, no. 7 (July 2019): 600–604. http://dx.doi.org/10.1093/jmcb/mjz071.
Повний текст джерелаLevine, Arnold J. "Targeting Therapies for the p53 Protein in Cancer Treatments." Annual Review of Cancer Biology 3, no. 1 (March 4, 2019): 21–34. http://dx.doi.org/10.1146/annurev-cancerbio-030518-055455.
Повний текст джерелаBellazzo, Arianna, Giulio Di Minin, and Licio Collavin. "Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancer." Molecular & Cellular Oncology 2, no. 4 (January 23, 2015): e1002719. http://dx.doi.org/10.1080/23723556.2014.1002719.
Повний текст джерелаWalerych, Dawid, Kamil Lisek, and Giannino Del Sal. "Multi-omics reveals global effects of mutant p53 gain-of-function." Cell Cycle 15, no. 22 (August 13, 2016): 3009–10. http://dx.doi.org/10.1080/15384101.2016.1215703.
Повний текст джерелаYan, Wensheng, and Xinbin Chen. "Characterization of Functional Domains Necessary for Mutant p53 Gain of Function." Journal of Biological Chemistry 285, no. 19 (March 8, 2010): 14229–38. http://dx.doi.org/10.1074/jbc.m109.097253.
Повний текст джерелаBillant, Olivier, Gaëlle Friocourt, Pierre Roux, and Cécile Voisset. "p53, A Victim of the Prion Fashion." Cancers 13, no. 2 (January 13, 2021): 269. http://dx.doi.org/10.3390/cancers13020269.
Повний текст джерелаBlandino, Giovanni, Arnold J. Levine, and Moshe Oren. "Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy." Oncogene 18, no. 2 (January 1999): 477–85. http://dx.doi.org/10.1038/sj.onc.1202314.
Повний текст джерелаZalcenstein, Amir, Perry Stambolsky, Lilach Weisz, Martina Müller, David Wallach, Tanya M. Goncharov, Peter H. Krammer, Varda Rotter, and Moshe Oren. "Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants." Oncogene 22, no. 36 (August 2003): 5667–76. http://dx.doi.org/10.1038/sj.onc.1206724.
Повний текст джерела